Who We Are

About Us

Committed to advancing the availability of innovative medical device biomaterials, SINTX is the only FDA registered and ISO 13485 2016 certified silicon nitride medical device manufacturing facility in the world.

SINTX Company History
Our Proprietary Products

Our Proprietary Products

SINTX Technologies was founded as Amedica Corporation in Salt Lake City, UT in 1996 by a material scientist and orthopedic surgeon who had the vision to develop an advanced ceramic for use in the human body.  Our initial focus was in arthroplasty, but we entered the spine market in 2007 when we obtained the first FDA approval on our implantable device. In 2009, we moved from an incubator into our state-of-the-art manufacturing facility.  In 2010, we acquired the assets of US Spine and in 2014 we filed our IPO. Most recently, in 2018, we sold the retail spine business to CTL Medical and became SINTX Technologies. 

Our Vision

We are passionate about leveraging our advanced biomaterial expertise to create innovative healthcare solutions that improve patient quality of life.

From Material to Medicine
What Makes a Biomaterial Ideal

What Makes a Biomaterial Ideal

Innovations in Interbody Fusion

Silicon nitride offer advantages over other commonly used materials.

Learn More

Patenting Innovative Technology

14* Patents Issued, 5 Patents Pending

13

United States

1

International

Source

*SINTX Technologies sold forty-five (45) spine-related patents as part of the sale of the retail spine business to CTL Medical in October 2018.

Superb People Behind the Product

Our seasoned management team possesses expertise and success in science, manufacturing and product development.